BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16856925)

  • 1. del(6)(p23) in two cases of de novo AML--a new recurrent primary chromosome abnormality.
    Anwar Iqbal M; Al-Omar HM; Owaidah T; Al-Humaidan H; Bhuiyan ZA; Sahovic E
    Eur J Haematol; 2006 Sep; 77(3):245-50. PubMed ID: 16856925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion 15q as the sole abnormality in acute myeloid leukemia: report of three cases and review of the literature.
    Lu G; Yin CC; Medeiros LJ; Abruzzo LV
    Cancer Genet Cytogenet; 2009 Jan; 188(2):118-23. PubMed ID: 19100517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion 6p23 and add(11)(p15) leading to NUP98 translocation in a case of therapy-related atypical chronic myelocytic leukemia transforming to acute myelocytic leukemia.
    Takeshita A; Naito K; Shinjo K; Sahara N; Matsui H; Ohnishi K; Beppu H; Ohtsubo K; Horii T; Maekawa M; Inaba T; Ohno R
    Cancer Genet Cytogenet; 2004 Jul; 152(1):56-60. PubMed ID: 15193442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization.
    Klaus M; Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
    Cancer Genet Cytogenet; 2004 Nov; 155(1):47-56. PubMed ID: 15527902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
    Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of chromosome arm 15q in a case of minimally differentiated hypoplastic AML-M0.
    Fujieda A; Masuya M; Kitano S; Miyazaki K; Yazaki A; Sugimoto Y; Usui E; Miyata E; Shibasaki T; Yamamura K; Ohishi K; Nishii K; Nakase K; Takeuchi T; Katayama N
    Cancer Genet Cytogenet; 2008 Jul; 184(1):57-61. PubMed ID: 18558291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
    Trost D; Hildebrandt B; Beier M; Müller N; Germing U; Royer-Pokora B
    Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
    Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
    Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocations involving 6p22 in acute myeloid leukaemia at relapse: breakpoint characterization using microarray-based comparative genomic hybridization.
    Tchinda J; Dijkhuizen T; Vlies Pv Pv; Kok K; Horst J
    Br J Haematol; 2004 Aug; 126(4):495-500. PubMed ID: 15287941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of fluorescence in situ hybridization for the detection of genomic aberrations in older patients with acute myeloid leukemia.
    Fröhling S; Kayser S; Mayer C; Miller S; Wieland C; Skelin S; Schlenk RF; Döhner H; Döhner K;
    Haematologica; 2005 Feb; 90(2):194-9. PubMed ID: 15710571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trisomy 22 as the sole abnormality is an important marker for the diagnosis of acute myeloid leukemia with inversion 16.
    Xu W; Zhou HF; Fan L; Qian SX; Chen LJ; Qiu HR; Zhang SJ; Li JY
    Onkologie; 2008 Sep; 31(8-9):440-4. PubMed ID: 18787351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletions of chromosome arms 7p and 7q in adult acute myeloid leukemia: a marker chromosome confirmed by array comparative genomic hybridization.
    Woo KS; Kim KE; Kim KH; Kim SH; Park JI; Shaffer LG; Han JY
    Cancer Genet Cytogenet; 2009 Oct; 194(2):71-4. PubMed ID: 19781438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent in situ hybridization (FISH) in bone marrow and peripheral blood of leukemia patients: implications for occupational surveillance.
    McDevitt MA; Condon M; Stamberg J; Karp JE; McDiarmid M
    Mutat Res; 2007 Apr; 629(1):24-31. PubMed ID: 17276720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; De Braekeleer M
    Eur J Haematol; 2007 Jun; 78(6):457-67. PubMed ID: 17391336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and molecular cytogenetic features of myeloid diseases characterized by i(20q-): a study of seven cases].
    Li TY; Xue YQ; Wu YF; Pan JL; Liu DD; Gong SL
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):732-5. PubMed ID: 15200909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematological, immunophenotypic, and cytogenetic characteristics of acute myeloblastic leukemia with trisomy 11.
    Sierra M; Hernández JM; García JL; Gutiérrez NC; Pérez JJ; Vidriales MB; Ramos F; Hernández JM; Romero M; González MB; Galende J; San Miguel JF
    Cancer Genet Cytogenet; 2005 Jul; 160(1):68-72. PubMed ID: 15949573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic, morphological, and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia.
    Udayakumar AM; Pathare AV; Al-Kindi S; Khan H; Rehmen JU; Zia F; Al-Ghazaly A; Nusrut N; Khan MI; Wali YA; Al-Lamki Z; Dennison D; Raeburn JA
    Cancer Genet Cytogenet; 2007 Sep; 177(2):89-94. PubMed ID: 17854660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemia.
    Casas S; Aventín A; Fuentes F; Vallespí T; Granada I; Carrió A; Angel Martínez-Climent J; Solé F; Teixidó M; Bernués M; Duarte J; Maria Hernández J; Brunet S; Dolors Coll M; Sierra J
    Cancer Genet Cytogenet; 2004 Aug; 153(1):16-25. PubMed ID: 15325089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The route to development of myelodysplastic syndrome/acute myeloid leukaemia in Shwachman-Diamond syndrome: the role of ageing, karyotype instability, and acquired chromosome anomalies.
    Maserati E; Pressato B; Valli R; Minelli A; Sainati L; Patitucci F; Marletta C; Mastronuzzi A; Poli F; Lo Curto F; Locatelli F; Danesino C; Pasquali F
    Br J Haematol; 2009 Apr; 145(2):190-7. PubMed ID: 19222471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.